Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-10-11

Clinical Trial Update: Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of Bictegravir in adults with normal and impaired renal function completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bictegravir (bictegravir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV | Phase 1 | Status: COMPLETED | Results posted: 2019-10-11